These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
542 related items for PubMed ID: 26656320
1. Complete Remission in the Nephrotic Syndrome Study Network. Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson PJ, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova O, Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, Mokrzycki MH, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M. Clin J Am Soc Nephrol; 2016 Jan 07; 11(1):81-9. PubMed ID: 26656320 [Abstract] [Full Text] [Related]
2. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS. Laurin LP, Gasim AM, Derebail VK, McGregor JG, Kidd JM, Hogan SL, Poulton CJ, Detwiler RK, Jennette JC, Falk RJ, Nachman PH. Clin J Am Soc Nephrol; 2016 Oct 07; 11(10):1752-1759. PubMed ID: 27445167 [Abstract] [Full Text] [Related]
3. Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. Mariani LH, Martini S, Barisoni L, Canetta PA, Troost JP, Hodgin JB, Palmer M, Rosenberg AZ, Lemley KV, Chien HP, Zee J, Smith A, Appel GB, Trachtman H, Hewitt SM, Kretzler M, Bagnasco SM. Nephrol Dial Transplant; 2018 Feb 01; 33(2):310-318. PubMed ID: 28339906 [Abstract] [Full Text] [Related]
4. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS). Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y. Clin Exp Nephrol; 2020 Jun 01; 24(6):526-540. PubMed ID: 32146646 [Abstract] [Full Text] [Related]
5. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD. Kidney Int; 2003 Oct 01; 64(4):1232-40. PubMed ID: 12969141 [Abstract] [Full Text] [Related]
6. Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome. Hodgin JB, Mariani LH, Zee J, Liu Q, Smith AR, Eddy S, Hartman J, Hamidi H, Gaut JP, Palmer MB, Nast CC, Chang A, Hewitt S, Gillespie BW, Kretzler M, Holzman LB, Barisoni L, Nephrotic Syndrome Study Network (NEPTUNE). Am J Kidney Dis; 2022 Jun 01; 79(6):807-819.e1. PubMed ID: 34864148 [Abstract] [Full Text] [Related]
7. An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis. Troost JP, Trachtman H, Nachman PH, Kretzler M, Spino C, Komers R, Tuller S, Perumal K, Massengill SF, Kamil ES, Oh G, Selewski DT, Gipson P, Gipson DS. Clin J Am Soc Nephrol; 2018 Mar 07; 13(3):414-421. PubMed ID: 29167190 [Abstract] [Full Text] [Related]
8. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J. Am J Kidney Dis; 2009 Jul 07; 54(1):51-8. PubMed ID: 19406543 [Abstract] [Full Text] [Related]
9. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Bazzi C, Petrini C, Rizza V, Arrigo G, Napodano P, Paparella M, D'Amico G. Nephrol Dial Transplant; 2002 Nov 07; 17(11):1890-6. PubMed ID: 12401843 [Abstract] [Full Text] [Related]
10. Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis. Gipson DS, Troost JP, Spino C, Attalla S, Tarnoff J, Massengill S, Lafayette R, Vega-Warner V, Adler S, Gipson P, Elliott M, Kaskel F, Fermin D, Moxey-Mims M, Fine RN, Brown EJ, Reidy K, Tuttle K, Gibson K, Lemley KV, Greenbaum LA, Atkinson MA, Hingorani S, Srivastava T, Sethna CB, Meyers K, Tran C, Dell KM, Wang CS, Yee JL, Sampson MG, Gbadegesin R, Lin JJ, Brady T, Rheault M, Trachtman H. JAMA Netw Open; 2022 Aug 01; 5(8):e2228701. PubMed ID: 36006643 [Abstract] [Full Text] [Related]
11. Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment. Hommos MS, Zeng C, Liu Z, Troost JP, Rosenberg AZ, Palmer M, Kremers WK, Cornell LD, Fervenza FC, Barisoni L, Rule AD. Kidney Int; 2018 May 01; 93(5):1175-1182. PubMed ID: 29273332 [Abstract] [Full Text] [Related]
12. Differential risk of remission and ESRD in childhood FSGS. Gipson DS, Chin H, Presler TP, Jennette C, Ferris ME, Massengill S, Gibson K, Thomas DB. Pediatr Nephrol; 2006 Mar 01; 21(3):344-9. PubMed ID: 16395603 [Abstract] [Full Text] [Related]
13. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial. Bomback AS, Canetta PA, Beck LH, Ayalon R, Radhakrishnan J, Appel GB. Am J Nephrol; 2012 Mar 01; 36(1):58-67. PubMed ID: 22722778 [Abstract] [Full Text] [Related]
14. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Bazzi C, Petrini C, Rizza V, Arrigo G, D'Amico G. Kidney Int; 2000 Oct 01; 58(4):1732-41. PubMed ID: 11012907 [Abstract] [Full Text] [Related]
15. Clinical-Morphological Features and Outcomes of Lupus Podocytopathy. Hu W, Chen Y, Wang S, Chen H, Liu Z, Zeng C, Zhang H, Liu Z. Clin J Am Soc Nephrol; 2016 Apr 07; 11(4):585-92. PubMed ID: 26983707 [Abstract] [Full Text] [Related]
16. The Significance of Hematuria in Podocytopathies. Marchel D, Trachtman H, Larkina M, Helmuth M, Lai Yee JY, Fermin D, Bomback AS, Canetta PA, Gipson DS, Mottl AK, Parekh RS, Saha MK, Sampson MG, Lafayette RA, Mariani LH, Nephrotic Syndrome Study Network (NEPTUNE) and Cure Glomerulonephropathy (CureGN). Clin J Am Soc Nephrol; 2024 Jan 01; 19(1):56-66. PubMed ID: 37733352 [Abstract] [Full Text] [Related]
17. Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial. Chen Y, Deng Y, Ni Z, Chen N, Chen X, Shi W, Zhan Y, Yuan F, Deng W, Zhong Y. Am J Kidney Dis; 2013 Dec 01; 62(6):1068-76. PubMed ID: 23810688 [Abstract] [Full Text] [Related]
18. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy. Bazzi C, Usui T, Rizza V, Casellato D, Gallieni M, Nangaku M. Nephrology (Carlton); 2018 Feb 01; 23(2):175-182. PubMed ID: 27764902 [Abstract] [Full Text] [Related]
19. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin. Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G. Am J Kidney Dis; 1997 Sep 01; 30(3):404-12. PubMed ID: 9292570 [Abstract] [Full Text] [Related]
20. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series. Madan A, Mijovic-Das S, Stankovic A, Teehan G, Milward AS, Khastgir A. BMC Nephrol; 2016 Mar 31; 17():37. PubMed ID: 27036111 [Abstract] [Full Text] [Related] Page: [Next] [New Search]